Shape 21 Experience
    Shape 21 Experience
      1. Home
      2. Address the COVID-19 pandemic in your molecular lab

      Address the COVID-19 pandemic in your molecular lab

      Address the COVID-19 pandemic in your molecular lab

      Real-time PCR Assay for the specific detection of the coronavirus causing COVID-19

      Requirements for testing and managing COVID-19 patients will change over time

      Early detection with real-time PCR testing is vital to address the challenge of the COVID-19 pandemic.

      Watch the Respiratory Testing Solutions Video

      FTD SARS-CoV-2 Assay

      In response to the current outbreak of Coronavirus disease (COVID-19), the new FTD SARS-CoV-2 real time PCR assay1 is now available for molecular laboratories. A dual-target design for SARS-CoV-2 identification provides assay robustness and high sensitivity.

      Molecular testing is critical to understanding an infectious disease outbreak, and our RT-PCR assay is fundamental to determining current infection.

      VERSANT kPCR Molecular System Overview

      FTD SARS-CoV-2 Assay Overview

      The FTD SARS-CoV-2 Assay is a real-time PCR test used to detect the new coronavirus SARS-CoV-2 causing COVID-19. The FTD SARS-CoV-2 Assay uses the same protocol, including PCR cycling profile, as other CE-IVD marked FTD respiratory assays.

      DX MD Tubes

      Dual-Targeting for Quality SARS-CoV-2 Detection

      The FTD SARS-CoV-2 Assay has an innovative dual-target design that probes two highly conserved regions on the SARS-CoV-2 genome. This feature increases confidence in your laboratory results.

      Dual-target design and mutations 

      Dr. Petra Leidinger-Kaufmann

      How can we manage mutations of the SARS-CoV-2 virus?

      Test your respiratory testing knowledge!

      In addition to flu viruses, several other respiratory viruses also circulate during the flu season and can cause symptoms and illness similar to those seen with flu infection. Test your knowledge to learn more!

      Small amounts of RNA can be detected early with the assay before an immune response when antibodies are detectable.

      Siemens Healthineers offers solutions for the detection of more than twenty different respiratory pathogens including the new Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

      Acute respiratory infections are a leading cause of death.

      1

      CE-IVD labeled for diagnostic use in the EU. This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21. U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.